TBPH Net Receivables
Theravance Biopharma Inc · Net Receivables
TBPH Net Receivables
Latest reported$95.54Mperiod ending
TBPH FY Net Receivables ($424.00K → $95.54M)
Annual net receivables
High-resolution chart · PNG
TBPH net receivables history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 95,539,000 | |
| 68,440,000 | |
| 17,474,000 | |
| 16,785,000 | |
| 57,599,000 | |
| 69,667,000 | |
| 50,570,000 | |
| 10,673,000 | |
| 9,362,000 | |
| 9,722,000 | |
| 37,154,000 | |
| 2,129,000 | |
| 1,133,000 | |
| 1,040,999 | |
| 424,000 |